Meetings: Advisory Committee to Director,

[Federal Register: April 2, 1999 (Volume 64, Number 63)]

[Notices]

[Page 15980]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr02ap99-54]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

Notice of Meeting of the Working Group To Advise the ACD on Guidelines and Oversight Process for Research Involving Human Pluripotent Stem Cells

Notice is hereby given that the Working Group of the Advisory Committee to the Director (ACD), NIH to advise the ACD on guidelines and oversight for research involving human pluripotent stem cells, will meet in public session at the Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, Maryland 20814, on April 8, 1999. The meeting will begin at approximately 9:00 a.m. and end at approximately 5:30 p.m.

The goal of the Working Group is to provide advice to the ACD about the scientific, ethical, legal, and social issues relevant to guidelines for the conduct of research utilizing human pluripotent stem cells (cells that can form most of the cells and tissues of the body) and to consider oversight options for this research.

A limited amount of meeting time will be allotted for public testimony. Individuals who wish to give five minute public testimony may sign up at the meeting site the morning of the meeting on a first come, first served basis. Written testimony may be submitted to: the Office of Science Policy, Bldg. 1, Room 218, NIH, 9000 Rockville Pike, Bethesda 20892.

Attendance may be limited to seat availability. Ruth L. Kirschstein, Deputy Director, NIH.

[FR Doc. 99-8096Filed4-1-99; 8:45 am]

BILLING CODE 4140-01-P